Finished format
Dosage form, pouch, E-Liquid / ENDS or research program.
Applications
Start with what you make.
Compare nicotine forms across pharmaceutical & NRT, nicotine pouches, E-Liquid / ENDS and R&D, then move directly to the relevant product family.
APPLICATION
NICOTINE FORM
Freebase nicotinePure nicotine / alkaloid
Nicotine saltsBitartrate + selected salt forms
Resin-boundPolacrilex
Prepared dilutionsVG / PG
ONE APPLICATION CAN MAP TO MORE THAN ONE NICOTINE FORM.
Selection path
What determines the material choice.
The application narrows the field, but product selection still depends on the nicotine form, formulation requirements and specification your program needs.
Nicotine form
Freebase, salt, resin-bound material or prepared dilution.
Formulation requirements
Target concentration, release behavior, carrier, handling and process conditions.
Specification & evidence
Required grade, analytical criteria and supporting documentation.
Applications × Products
Nicotine products by application.
Use the matrix to identify product families worth evaluating. Final fit depends on formulation, process, target specification and regulatory requirements.
ApplicationProduct family
01Pure NicotineUSP / Ph. Eur.
02Alkaloid 95%Intermediate route
03PolacrilexResin complex
04BitartrateDihydrate
05Nicotine SaltsSalt routes
06DilutionsPrepared formats
Pharmaceutical & NRTFreebase, resin-bound and crystalline salt forms.
Evaluate
—
Evaluate
Evaluate
—
—
Nicotine PouchesFreebase and selected salt-form inputs.
Evaluate
—
—
Evaluate
Evaluate
—
E-Liquid / ENDSFreebase, salt and prepared dilution formats.
Evaluate
—
—
—
Evaluate
Evaluate
Research & DevelopmentCross-portfolio material comparison and development.
Evaluate
Evaluate
Evaluate
Evaluate
Evaluate
Evaluate
Pharmaceutical & NRT
Programs may evaluate high-purity freebase nicotine, resin-bound polacrilex or crystalline bitartrate depending on dosage form, release behavior, physical form and target specification.
Nicotine Pouches
Pouch formulations may evaluate freebase nicotine or selected nicotine salts depending on formulation chemistry, physical-form preference, target nicotine concentration and processing requirements.
E-Liquid / ENDS
Formulation can begin with high-purity freebase nicotine, a selected salt chemistry or a prepared VG / PG dilution, depending on the target product and manufacturing process.
Research & Development
Research programs can compare nicotine across freebase, concentrated extract, resin-bound, crystalline salt, salt chemistry and prepared dilution formats depending on the analytical, formulation or process question.
Pure NicotineHigh-purity freebase reference point.↗Alkaloid 95%Concentrated extract for downstream processing or evaluation.↗Nicotine PolacrilexResin-bound form with defined loading and release behavior.↗Bitartrate DihydrateCrystalline solid nicotine salt.↗Nicotine SaltsSeparate Benzoate and Salicylate chemistries.↗Nicotine DilutionsPrepared VG / PG concentrations for formulation work.↗
Mapping identifies product families that may warrant evaluation, not suitability for a specific formulation or regulatory pathway. For a commercial inquiry, send the application, required nicotine form or specification, quantity and destination.
Discuss your application ↗